GPX4 and metabolic dysfunction-associated steatohepatitis: At the molecular level, the increase in KEAP1 and the decreases in Nrf-2, FTH1, and GPX4 caused by NASH were reversed when 3-MA intervention was applied, emphasizing its protective function against ferroptosis.